These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31649535)

  • 1. Dual Inhibition of Pirarubicin-Induced
    Peng M; Deng J; Zhou S; Xiao D; Long J; Zhang N; He C; Mo M; Yang X
    Front Pharmacol; 2019; 10():1159. PubMed ID: 31649535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
    Meng J; Dai B; Fang B; Bekele BN; Bornmann WG; Sun D; Peng Z; Herbst RS; Papadimitrakopoulou V; Minna JD; Peyton M; Roth JA
    PLoS One; 2010 Nov; 5(11):e14124. PubMed ID: 21124782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer.
    Park H; Kim Y; Sul JW; Jeong IG; Yi HJ; Ahn JB; Kang JS; Yun J; Hwang JJ; Kim CS
    Prostate; 2015 Nov; 75(15):1747-59. PubMed ID: 26250606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Akt inhibitor MK2206 synergizes, but perifosine antagonizes, the BRAF(V600E) inhibitor PLX4032 and the MEK1/2 inhibitor AZD6244 in the inhibition of thyroid cancer cells.
    Liu R; Liu D; Xing M
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E173-82. PubMed ID: 22090271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways.
    Kandil E; Tsumagari K; Ma J; Abd Elmageed ZY; Li X; Slakey D; Mondal D; Abdel-Mageed AB
    J Surg Res; 2013 Oct; 184(2):898-906. PubMed ID: 23602735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR.
    Veiga SR; Ge X; Mercer CA; Hernández-Álvarez MI; Thomas HE; Hernandez-Losa J; Ramón Y Cajal S; Zorzano A; Thomas G; Kozma SC
    Clin Cancer Res; 2018 Aug; 24(15):3767-3780. PubMed ID: 29691292
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.
    Matsuzaki S; Darcha C
    Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.
    Renshaw J; Taylor KR; Bishop R; Valenti M; De Haven Brandon A; Gowan S; Eccles SA; Ruddle RR; Johnson LD; Raynaud FI; Selfe JL; Thway K; Pietsch T; Pearson AD; Shipley J
    Clin Cancer Res; 2013 Nov; 19(21):5940-51. PubMed ID: 23918606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
    Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
    Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenformin synergistically sensitizes liver cancer cells to sorafenib by downregulating CRAF/ERK and PI3K/AKT/mTOR pathways.
    Huang L; Xiao D; Wu T; Hu X; Deng J; Yan X; Wu J; Xu S; Yang X; Li G
    Am J Transl Res; 2021; 13(7):7508-7523. PubMed ID: 34377232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1 Inhibition Enhances Pirarubicin Cytotoxic Efficacy through AKT-P21-dependent Pathway in Hepatocellular Carcinoma.
    Huang H; Chen T; Zhou Y; Geng L; Shen T; Zhou L; Zheng S
    Int J Med Sci; 2018; 15(14):1648-1657. PubMed ID: 30588188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors.
    Ewald F; Nörz D; Grottke A; Hofmann BT; Nashan B; Jücker M
    Invest New Drugs; 2014 Dec; 32(6):1144-54. PubMed ID: 25152244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells.
    Adam RM; Roth JA; Cheng HL; Rice DC; Khoury J; Bauer SB; Peters CA; Freeman MR
    J Urol; 2003 Jun; 169(6):2388-93. PubMed ID: 12771803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models.
    Stulpinas A; Sereika M; Vitkeviciene A; Imbrasaite A; Krestnikova N; Kalvelyte AV
    Front Oncol; 2022; 12():1045521. PubMed ID: 36686779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion.
    Zhou J; Du T; Li B; Rong Y; Verkhratsky A; Peng L
    ASN Neuro; 2015; 7(5):. PubMed ID: 26442853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer.
    Chen G; He Y; Wu X; Zhang Y; Luo C; Jing P
    Braz J Med Biol Res; 2012 Aug; 45(8):771-6. PubMed ID: 22782557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer.
    Nie Z; Gao Y; Chen M; Peng Y; Guo N; Cao H; Huang D; Gao X; Zhang S
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Periploca forrestii Schltr on wound healing by Src meditated Mek/Erk and PI3K/Akt signals.
    Li J; Chen L; Xu J; Xie Z; Xu Y; Jiang P; Duan B; Huang X; Feng F; Liu W
    J Ethnopharmacol; 2019 Jun; 237():116-127. PubMed ID: 30905787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.